U.S. Semiconductors Stock News

Key Insights Jiayin Group's significant insider ownership suggests inherent interests in company's expansion The...

Key Insights The considerable ownership by retail investors in Elicio Therapeutics indicates that they collectively...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

We feel now is a pretty good time to analyse Sky Harbour Group Corporation's ( NYSE:SKYH ) business as it appears the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

LSB Industries, Inc. ( NYSE:LXU ), is not the largest company out there, but it saw a double-digit share price rise of...

Udemy, Inc. ( NASDAQ:UDMY ) shareholders that were waiting for something to happen have been dealt a blow with a 31...

Key Insights Significant control over Cardiff Oncology by individual investors implies that the general public has more...

Those following along with Sonos, Inc. ( NASDAQ:SONO ) will no doubt be intrigued by the recent purchase of shares by...

Key Insights Oxford Industries' estimated fair value is US$25.62 based on 2 Stage Free Cash Flow to Equity Oxford...

Phillip Frost, CEO and Chairman of OPKO Health, and Frost Gamma Investments Trust recently acquired US$737,747 worth of OPKO Health shares, significantly increasing Frost's ownership both directly and indirectly. This activity coincided with a downgrade from Jefferies, who shifted their rating from Buy to Hold due to concerns over flat sales guidance for Ngenla, a growth hormone product developed with Pfizer. To assess how insider buying by the CEO could influence OPKO Health’s outlook,...

Vanda Pharmaceuticals (VNDA) recently shared clinical trial results showing its drug tradipitant delivered clear benefits for patients experiencing nausea and vomiting from GLP-1 therapy with Wegovy. The trial met both key efficacy measures and reported no new safety concerns. See our latest analysis for Vanda Pharmaceuticals. Alongside the latest clinical win, Vanda’s share price recently surged 18% over the past week as investors digested upbeat trial news. However, momentum has been mixed;...

Wondering whether Maximus is a bargain or overvalued right now? If you are curious about the true worth of this stock, you are not alone. The share price has dipped 3.5% over the past week and is down 10.7% in the last month, but is still up 2.6% year-to-date. This gives mixed signals about investor sentiment and potential risk or growth. Maximus has recently been in the spotlight following several key contract announcements and expansion news. These updates related to government services...

LifeMD (LFMD) turned heads after releasing a mix of disappointing third-quarter earnings and a downward revision to its 2025 revenue and EBITDA forecasts, following its decision to divest its stake in WorkSimpli. See our latest analysis for LifeMD. LifeMD’s share price has tumbled in recent weeks, with a 1-day return of -2.44% capping off a much steeper 7-day decline of -21.3% as the market reacted to the lowered 2025 outlook and WorkSimpli divestiture. The one-year total shareholder return...

Premier (PINC) shares have been steady as the overall healthcare sector remains in focus. The company’s recent performance has gradually caught investors’ eyes, especially with year-to-date returns climbing over 31% and positive momentum observed over the past 3 months. See our latest analysis for Premier. Premier’s share price has surged this year, recording a robust 32% year-to-date gain and attracting attention for its strong momentum over the last quarter. While its long-term total...

The Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) share price has done very well over the last month, posting an...

Major stock indexes in the United States have mostly risen, with investors eagerly anticipating Nvidia's earnings report, which could influence broader market trends. Though the term 'penny stock' might sound like a relic of past trading days, the opportunity it points to is still relevant. These smaller or newer companies, when built on solid financials, can lead to significant returns. We've selected three examples of penny stocks that combine balance sheet strength with potential for...

As the U.S. stock market navigates a period of mixed performance, with major indices like the S&P 500 and Nasdaq showing slight gains while others face pressure from AI-related valuation concerns, investors are keenly observing upcoming earnings reports and economic data releases. In this environment, dividend stocks can offer stability and income potential, making them an attractive option for those looking to balance growth with reliable returns amidst market fluctuations.

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

We wouldn't blame Flotek Industries, Inc. ( NYSE:FTK ) shareholders if they were a little worried about the fact that...

Virco Mfg. Corporation ( NASDAQ:VIRC ) shareholders might be concerned after seeing the share price drop 20% in the...

Daktronics, Inc. ( NASDAQ:DAKT ), might not be a large cap stock, but it saw a double-digit share price rise of over...

As the U.S. stock market faces a period of volatility, with major indices like the S&P 500 experiencing consecutive declines amid pressure on tech stocks, investors are increasingly looking for opportunities beyond well-known giants. Penny stocks, despite their old-fashioned moniker, continue to attract attention as they represent smaller or newer companies that can offer unique value propositions. By focusing on those with strong financials and potential for growth, investors may find...